We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Looks to Sell Drugmakers on Benefits of Generic User Fees
FDA Looks to Sell Drugmakers on Benefits of Generic User Fees
September 24, 2010
As the FDA begins its long-awaited attempt to create a system of user fees for generic drugs, the agency is looking to sell drugmakers on the program while, at the same time, warning of the consequences if it is not established.